Tobrex Ointment
Product Images NDC 0078-0813

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tobrex (NDC 0078-0813). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel Ndc 0078-0813-01 Tobrex® (tobramycin Ophthalmic Ointment) 0.3% Sterile 3.5 G Net Wt. Novartis (Carton)

Tobrex (tobramycin ophthalmic ointment) 0.3% sterile ointment packaging label showing 3.5 g net weight. The label indicates manufacture by S.A. Alcon-Couvreur N.V., Puurs, Belgium and distribution by Novartis Pharmaceuticals Corporation, East Hanover, NJ. The packaging features the Novartis logo, NDC 0078-0813-01, and barcode details.*

FDA Label Image

Chemical Structure Of Tobramycin (Chemical)

Chemical structure diagram of the active ingredient tobramycin. The diagram displays molecular rings and functional groups associated with the tobramycin molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.